Elsevier

Clinical Prostate Cancer

Volume 4, Issue 2, September 2005, Pages 109-112
Clinical Prostate Cancer

Original Contribution
Quantitative Computed Tomography Perfusion of Prostate Cancer: Correlation with Whole-Mount Pathology

https://doi.org/10.3816/CGC.2005.n.018Get rights and content

Abstract

Purpose

Microvessel density within the prostate is associated with presence of cancer, disease stage, and disease-specific survival. We evaluated multidetector computed tomography (CT) to estimate prostate perfusion and localize prostate cancer.

Patients and Methods

Ten subjects were evaluated with contrast enhanced CT before radical prostatectomy with the Mx8000IDT 16-slice scanner. Following baseline pelvic scan, 100 cc of Optiray® 300 was administered intravenously (4 cc per second). Repeated dynamic scans through the prostate were obtained at 20, 30, 40, 50, and 60 seconds following initiation of contrast injection. Computed tomography perfusion was compared with pathologic findings of Gleason score and tumor volume on whole-mount prostatectomy specimens.

Results

Conventional adenocarcinoma (Gleason score, 6-10) was present in all subjects, including one who also demonstrated a mucinous variant of prostate cancer. Visible focal CT enhancement was noted in 1 patient with a high-volume tumor and a Gleason score of 10. A positive correlation between local estimates of CT perfusion and percent of prostate volume occupied by tumor in each sextant was found for half of the subjects (Pearson correlation coefficient, 0.3-0.95; mean, 0.48) but statistically significant correlation (P < 0.05; Pearson coefficient, 0.9- 0.95) was present in only the 2 subjects with the highest Gleason scores (8 and 10) and the highest tumor volume (≥ 50% in ≥ 1 sextant region).

Conclusion

Visible enhancement of prostate cancer during dynamic CT is present in a minority of subjects. Correlation between quantitative CT perfusion and tumor location is statistically significant only in subjects with localized high-volume, poorly differentiated prostate cancer.

References (31)

  • IF Lissbrant et al.

    Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

    Prostate

    (1997)
  • M Borre et al.

    Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

    Br J Cancer

    (1998)
  • MK Brawer

    Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma

    Cancer

    (1996)
  • MD Rifkin et al.

    Prostate: techniques, results and potential applications of color Doppler US scanning

    Radiology

    (1993)
  • GS Sudakoff et al.

    Color Doppler imaging and transrectal sonography of the prostatic fossa after radical prostatectomy: early experience

    AJR Am J Roentgenol

    (1996)
  • Cited by (35)

    • Perfusion change in benign prostatic hyperplasia before and after castration in a canine model: Contrast enhanced ultrasonography and CT perfusion study

      2020, Theriogenology
      Citation Excerpt :

      Blood volume is the amount of blood contained within the vasculature of 1000 mL of tissue. Several studies have used CTP to evaluate cases with prostatic cancer [18–20]. However, to the best of the authors’ knowledge, perfusion changes in cases with BPH have not been investigated using CTP.

    • Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT?

      2015, Clinical Imaging
      Citation Excerpt :

      In our study, a subgroup analysis revealed a significant improvement in detection of GS 9–10 compared to GS 7–8 and score 6 tumors and a trend towards improved detection rates when comparing GS 7–8 to GS 6 tumors. This finding would be supported by other studies of dynamic CECT in prostatic carcinoma, which have shown a correlation between enhancement/perfusion at CECT and Gleason grade and microvessel density [23,24] and is also supported by the recent results by Glazer et al. which showed that focal enhancement is specific for GS ≥ 4=3=7 cancer [5]. The results of our study confirm our hypothesis that GS ≥ 7 primary tumors are reliably and reproducibly detectable at routine CECT.

    • PET in prostate and bladder tumors

      2012, Seminars in Nuclear Medicine
      Citation Excerpt :

      The results of this meta-analysis suggest that FDG-PET or PET/CT provides good diagnostic accuracy of lymph nodes; however, the application of FDG-PET or PET/CT in diagnosis and localized staging of bladder cancer is in some instances restricted by radiotracer urinary excretion (Fig. 7). In the same meta-analysis, there were 4 studies which used intravenous injection of frusemide,97,9-100,101,104 with 2 using delayed pelvic images after oral hydration and diuretic administration.97,104 In a study of 11 patients with invasive bladder cancer by Anjos et al,97 the reported sensitivity and the specificity for detection of bladder wall lesions were both 100%.

    View all citing articles on Scopus

    Electronic forwarding or copying is a violation of US and International Copyright Laws.

    Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Cancer Information Group, ISSN #1540-0352, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.

    View full text